CA2271582A1 - Method for administration of therapeutic agents ...,https://www.google.com/patents/CA2271582A1?cl=tr
EP1196626B1 - Methods for identifying inhibitors of signaling ...,https://www.google.com/patents/EP1196626B1?cl=ko
CA2749601A1 - Ratio based biomarkers and methods of use thereof,https://www.google.com/patents/CA2749601A1
EP2546337A1 - Means for inhibiting the expression of protein kinase 3,https://www.google.com/patents/EP2546337A1?cl=en15
WO2012069836A2 - Biologically active complex and its preparation ...,https://www.google.com/patents/WO2012069836A2?cl=ja
US8518948B2 - Inhibitors of protein kinases - Google Patents,https://www.google.com/patents/US8518948
WO2017027291A1 - Bispecific car t-cells for solid tumor targeting ...,https://www.google.com/patents/WO2017027291A1?cl=ko
WO2015164604A1 - Hydrophobically tagged janus kinase inhibitors ...,https://google.com/patents/WO2015164604A1?cl=tr
WO2012158843A2 - Kinase inhibitors - Google Patents,https://www.google.com/patents/WO2012158843A2
WO2015161230A1 - Methods of reducing kinase inhibitor resistance ...,https://www.google.com/patents/WO2015161230A1
